FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Guidance for Using De Novo Classification Process

FDA posts a guidance on De Novo Classification Process (Evaluation of Automatic Class III Designation) that provides recommendation on how to use the ...

Medical Devices

Guide on Sharing Patient Info Collected on Medical Devices

FDA issues a final guidance document entitled Manufacturers Sharing Patient-Specific Information from Medical Devices with Patients upon Request.

Federal Register

Comments Sought on Dispute Resolution Guidance Extension

Federal Register: FDA seeks comments on an information collection extension related to a guidance on formal dispute resolution on drug GMP issues.

Medical Devices

Guide on Labeling for Ultrasonic Surgical Aspirator Devices

FDA posts a guidance entitled: Product Labeling for Certain Ultrasonic Surgical Aspirator Devices that describes the agencys current thinking on such ...

Medical Devices

FDA Clears Nitiloops Nova Cross Extreme and BTK Catheters

FDA clears a Nitiloop 510(k) for the Nova Cross Extreme and Nova Cross BTK, dedicated microcatheters for use in conjunction with conventional guidewir...

Human Drugs

Tesaro sNDA for Varubi IV Approved

FDA approves a Tesaro supplemental NDA for Varubi (rolapitant) IV in combination with other antiemetic agents in adults for preventing delayed nausea ...

Federal Register

Guide on 510(k)s for Device Changes

Federal Register notice: FDA makes available a guidance entitled Deciding When to Submit a 510(k) for a Change to an Existing Device that clarifies wh...

Human Drugs

Achaogen Files NDA for New Antibiotic

Achaogen files an NDA for plazomicin, indicated for treating complicated urinary tract infections.

Human Drugs

Amneal Asks Forteo Generic Restrictions

Amneal Pharmaceuticals says FDA should not approve any ANDA citing its Forteo as the reference-listed drug that does not contain recombinant human par...

Human Drugs

Pediatric GERD Drug Development Guidance

FDA issues a draft guidance to help sponsors develop pediatric drugs to treat GERD.